Abstract
In the second decade of the 21st century, we have viewed with awe the seemingly limitless potential of molecular medicine—first unlocking the genetic and epigenetic aberrations that lead to cancer and ultimately developing specific therapies that lack the toxicity and inherent limitations of our
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical cancer research : an official journal of the American Association for Cancer Research
Paper Title
Journal
Date
